Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Lipi Shugan Fang Granule Simulant is a Traditional Chinese Medicine (TCM) formula, presented as a research or experimental granule preparation designed to mimic a traditional herbal granule dosage form. Its name reflects its primary therapeutic principles in TCM: 'Bushen' (tonifying the kidney), 'Lipi' (regulating the spleen), and 'Shugan' (soothing the liver). As a multi-herb combination, its mechanism of action is understood through the synergistic effects of its constituent herbs, aiming to restore balance and improve the functions of the kidney, spleen, and liver systems according to TCM theory. While specific modern pharmacological mechanisms for this exact 'simulant' are not widely detailed, similar TCM formulas are often studied for their effects on various physiological processes, including immune modulation, anti-inflammatory actions, and organ function support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Lipi Shugan Fang Granule Simulant.